drug · small molecule
patient view →darinaparsin
Phase 2updated 2mo agoby Solasia Pharma KK🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and mature t-cell and nk-cell non-hodgkin lymphoma and 6 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that